CVE-2017-12726
No exploitation reported by the sources we read.
- Published2018-02-15
- WeaknessCWE-798
Am I affected?
Debian, Ubuntu or Red Hat sometimes backport a fix without changing the upstream version number: such a version reads « to verify », never « affected ».With a domain, we read the version its public headers and pages expose. A distribution build can carry the fix under an older number.
Description
A Use of Hard-coded Password issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. Telnet on the pump uses hardcoded credentials, which can be used if the pump is configured to allow external communications. Smiths Medical assesses that it is not possible to upload files via Telnet and the impact of this vulnerability is limited to the communications module.
Timeline
dates in UTC- 2018-02-1510:29CVE publishedNVD
Observed activity
isMalicious corpus · updated 2026-10-23 21:37 UTCBlock these indicators
- Firewall list (EDL, text): https://api.ismalicious.com/edl/cve/CVE-2017-12726?format=txt
- CSV export: https://api.ismalicious.com/edl/cve/CVE-2017-12726?format=csv
- TAXII collection of exploited CVEs
- The EDL and CSV take an API key on the Pro plan.
Versions per branch
NVD| Branch | Affected | Fixed in | Source |
|---|---|---|---|
| 1.1 | = 1.1 | no fix published | NVD |
| 1.5 | = 1.5 | no fix published | NVD |
| 1.6 | = 1.6 | no fix published | NVD |
as publishedRanges as NVD and OSV publish them; a distribution’s build can be fixed under an older number.
Distribution builds and vendor advisories
Packages from OSV.dev and products from the vendors' CSAF advisories.
version not verifiedVersions not verified: read as OSV.dev and the vendors publish them, not checked against each vendor's release list.
Vendor advisories
Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump Vulnerabilities (Update A)
Medfusion 4000 Wireless Syringe Infusion Pump: Version 1.1 · Medfusion 4000 Wireless Syringe Infusion Pump: Version 1.6 · Medfusion 4000 Wireless Syringe Infusion Pump: Version 1.5
Fix
- Vendor fix CISA ICSMA-17-250-02A · 3 productsSmiths Medical has released update Version 1.6.1 to mitigate the vulnerabilities in the Medfusion 4000 Wireless Syringe Infusion Pump.
- Vendor fix CISA ICSMA-17-250-02A · 3 productsSmiths Medical recommends users apply the following defensive measures:
- Vendor fix CISA ICSMA-17-250-02A · 3 productsFor additional information about the vulnerabilities, proposed measures, or obtaining the product fix, contact Smiths Medical Technical Support at:
- Vendor fix CISA ICSMA-17-250-02A · 3 productsTel: +1 (800) 258 5361 or +01 614 210 7300
- Vendor fix CISA ICSMA-17-250-02A · 3 productsOnline: https://smiths-medical.custhelp.com/
- Vendor fix CISA ICSMA-17-250-02A · 3 productsEmail: info.asd@smiths-medical.com
Detection
- Nuclei template
- none so far ProjectDiscovery
- Exploit-DB
- no entry Exploit-DB
- Proof-of-concept repositories
- none listed PoC-in-GitHub
Sources
- NVDCVSS 3.07.3read 2026-10-23
- NVDCVSS 2.07.5read 2026-10-23
- NVDweakness (CWE)CWE-798read 2026-10-23
- FIRST EPSSEPSS score1.1 %2026-10-23
Technical details
- CVSS v3 Vector
- CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
- Published
- 2018-02-15
- Last Modified
- 2026-06-17
- NVD status
- Modified
Frequently asked questions
What is CVE-2017-12726?
Is CVE-2017-12726 actively exploited?
What is the CVSS score for CVE-2017-12726?
Hear about the next vulnerability in your software
Surveillance reads the versions in your stack — a domain, a lockfile or a list — checks each CVE against the ranges its sources publish, and alerts you when one you run is exploited or enters CISA KEV. A version it cannot read stays « version not verified ».
No credit card required · No monthly cap on website lookups · 250 API requests/month
Go further
- Following what attackers exploit right now? The CISA KEV additions of the month, with their patch deadlines.
- Running this software? Vulnerability monitoring alerts you to new vulnerabilities in your products.
Related vulnerabilities
Same product first, then the same vendor advisory and the same publication week.